Lucem Health Closes $7.7 Million in Series A

by Kay Aloha Villamor in May 10th, 2023

Lucem Health, a Davidson, N.C.-based provider of transformational clinical AI technology and solutions, announced that it closed $7.7 million in Series A funding.

The round was led by Mayo Clinic, Granger Management, and Mercy (St Louis), along with financing from existing investor Rally Ventures.

This funding will be used to advance the development of Lucem Health's platform for clinical AI solution deployment, grow the company's solution portfolio, and expand its sales and marketing capacity.

"AI has tremendous potential to transform and augment how physicians and providers practice medicine, make decisions and serve their patients. Yet, so far, we have barely scratched the surface of AI's potential in healthcare," said Sean Cassidy, founding CEO of Lucem Health. "We started Lucem Health to accelerate the integration of powerful AI-generated insights into care delivery workflows in a thoughtful, responsible way. In a challenging market for raising capital, we appreciate our investors' confidence and support."

The company helps clinical AI innovators transform data science into innovative, trusted solutions that can detect diseases earlier and optimize care delivery, positively impacting patient lives, improving the physician and provider experience, and ultimately producing improved outcomes. 

Company: Lucem Health

Raised: $7.7M

Round: Series A

Funding Month: May 2023

Lead Investors: Mayo Clinic, Granger Management, and Mercy

Additional Investors: Rally Ventures

Company Website:

Software Category: Clinical AI Platform

About the Company: Lucem Health transforms the science of clinical AI into trusted point-of-care solutions that scale. With its comprehensive, AI-agnostic platform for building, operationalizing, and improving clinical AI solutions, they bring the power and potential of clinical AI from the lab to the front lines of healthcare, where it can help clinicians deliver better care, improve patient outcomes, and lower costs. They envision a world in which clinicians detect problems before they become life-threatening and patients get world-class care, everywhere.  




Your cart